InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-49.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Baldasare Bryan T, Chief Financial Officer. Officer active across 1 company, notably Meridian Bioscience INC. Cumulatively, 4 disclosures have been recorded. Activity tracked since 4 November 2021. The latest transaction was disclosed on 15 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
1,985 shares@ US$17.920.041% mcap16.0% of flowCommon StockSEC:0001127602-21-031730:0
3,807 shares@ US$20.160.088% mcap34.0% of flowCommon StockSEC:0001127602-21-031110:0
32,557 sharesCommon StockSEC:0001127602-21-029298:0
10,593 shares0Common StockSEC:0001127602-21-028575:0
4 of 4 declarations
About Baldasare Bryan T
Bryan T. Baldasare is the Chief Financial Officer at Meridian Bioscience Inc. In this role, he is responsible for managing the company's finances, including financial planning and risk management. Bryan plays a crucial role in developing financial strategies to ensure the stability and growth of the organization.
